IGC Pharma's total assets for Q3 2025 were $9.08M, a decrease of -12.45% from the previous quarter. DE:IGS1 total liabilities were $2.82M for the fiscal quarter, a -5.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.